Published in Curr Med Chem on January 01, 2007
Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists. Bioorg Med Chem (2012) 0.76
Dissecting rapid estrogen signaling with conjugates. Steroids (2012) 0.75
Increased emperipolesis in megakaryocytes in a case of idiopathic thrombocytopenic purpura. Indian J Pathol Microbiol (2006) 2.07
Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes. J Natl Cancer Inst (2013) 1.45
Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm (2001) 1.22
Ophthalmoscopic abnormalities in adults with falciparum malaria. QJM (1998) 1.17
Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects. J Allergy Clin Immunol (2011) 1.13
Microfilariae in bone marrow aspiration smears, correlation with marrow hypoplasia: a report of six cases. Indian J Pathol Microbiol (2006) 1.09
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery. Nanomedicine (2008) 1.08
Prognostic significance of eye changes in cerebral malaria. J Assoc Physicians India (2000) 1.08
Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target (2004) 1.03
RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm (2003) 1.03
Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine. Mol Pharm (2011) 1.02
Preparation and pharmacodynamic evaluation of liposomes of indomethacin. Drug Dev Ind Pharm (2000) 0.97
TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms. J Immunol (2011) 0.96
Surface modified liposomes for nasal delivery of DNA vaccine. Vaccine (2008) 0.96
Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J (2010) 0.96
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J Drug Target (2007) 0.95
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm (2007) 0.95
Release kinetic studies of aspirin microcapsules from ethyl cellulose, cellulose acetate phthalate and their mixtures by emulsion solvent evaporation method. Sci Pharm (2009) 0.94
Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm (2005) 0.93
Thromboembolic complications in childhood nephrotic syndrome: a clinical profile. Clin Exp Nephrol (2013) 0.93
Recent progress in dendrimer-based nanocarriers. Crit Rev Ther Drug Carrier Syst (2006) 0.93
Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J Liposome Res (2010) 0.91
Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des (2009) 0.89
Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release (2009) 0.88
Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharm Sci (2001) 0.88
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer. J Immunol (2011) 0.88
Tunable elastin-like polypeptide hollow sphere as a high payload and controlled delivery gene depot. J Control Release (2011) 0.88
Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension. J Pharm Sci (2010) 0.87
Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci (2008) 0.87
Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance. Expert Opin Drug Deliv (2013) 0.87
Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J Drug Target (2006) 0.87
Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat. Drug Dev Ind Pharm (1998) 0.87
pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie (2002) 0.86
Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B. J Drug Target (2010) 0.86
Biomaterial-based scaffolds--current status and future directions. Expert Opin Drug Deliv (2014) 0.85
Histological and immunohistochemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol (2012) 0.85
Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies. Pharmazie (2000) 0.84
Implication of nanoparticles/microparticles in mucosal vaccine delivery. Expert Rev Vaccines (2007) 0.84
Dieulafoy disease of the stomach presenting as mass lesion--a case report. Indian J Pathol Microbiol (2005) 0.83
Advances in novel drug delivery strategies for breast cancer therapy. Artif Cells Blood Substit Immobil Biotechnol (2010) 0.83
Polysaccharide coated liposomes for oral immunization--development and characterization. Int J Pharm (2000) 0.83
The pilosebaceous unit: a pivotal route for topical drug delivery. Methods Find Exp Clin Pharmacol (2000) 0.83
Targeted delivery of thrombolytic agents: role of integrin receptors. Expert Opin Drug Deliv (2009) 0.83
Primary extramedullary solitary plasmacytoma of conjunctiva--a case report. Indian J Ophthalmol (1985) 0.82
Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats. Int J Pharm (2005) 0.82
Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India. Asian Pac J Allergy Immunol (2012) 0.82
Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol (2005) 0.82
Teaching neuroImages: Griscelli syndrome and CNS lymphohistiocytosis. Neurology (2014) 0.82
Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett (2005) 0.82
A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy. Curr Cancer Drug Targets (2010) 0.82
Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation. J Drug Target (2010) 0.81
siRNA delivery using nanocarriers - an efficient tool for gene silencing. Curr Gene Ther (2010) 0.81
Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine. J Control Release (2009) 0.81
Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy. Mol Pharm (2011) 0.81
Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int J Pharm (2005) 0.81
Proliposomes of indomethacin for oral administration. J Microencapsul (1991) 0.80
Preparation and characterization of niosomes containing rifampicin for lung targeting. J Microencapsul (1996) 0.80
Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm (2004) 0.80
Long-circulating liposomes of indomethacin in arthritic rats--a biodisposition study. Pharm Acta Helv (2000) 0.80
Localized rifampicin albumin microspheres. J Microencapsul (1991) 0.80
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine (2011) 0.80
Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target (2011) 0.80
Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting. Curr Mol Med (2013) 0.80
Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin. Drug Dev Ind Pharm (2010) 0.80
Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies. Pharm Res (2001) 0.80
Nanotechnology: a magic bullet for HIV AIDS treatment. Artif Cells Nanomed Biotechnol (2014) 0.80
Mannosylated liposomes for targeted vaccines delivery. Methods Mol Biol (2010) 0.79
PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharm (2009) 0.79
Topical liposome system bearing local anaesthetic lignocaine: preparation and evaluation. J Microencapsul (1994) 0.79
Implication of gut immunology in the design of oral vaccines. Curr Mol Med (2010) 0.79
Synthetic peptides: a modern approach to vaccination. Indian J Exp Biol (1998) 0.79
Gel core liposomes: an advanced carrier for improved vaccine delivery. J Microencapsul (2009) 0.79
Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization. J Liposome Res (2006) 0.79
Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine (2006) 0.79